The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Home

Found 358 results
Filters: Author is Anushka Patel
2009
Bi Y, Gao R, Patel A, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Sydromes in China (CPACS) study. American Heart Journal. 2009; 157:509-516. .
Webster RJ, Heeley E, Bayram C, Peiris D, Cass A, Patel A. Gaps in cardiovascular disease risk management in Australian general practice. Medical Journal of Australia. 2009;191:324-9.
Patel A, Peiris D, Groenestein P. How to Treat – Cardiovascular Disease Risk Assessment. Australian Doctor. 2009:25-31.
Patel A. Impact of glucose control on macrovascular and microvascular disease: insights from ADVANCE. In: American Heart Association Scientific Sessions. American Heart Association Scientific Sessions. Orlando, US; 2009.
Turnbull F, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288-98.
Patel A, Chalmers J, Macmahon S, Neal B. [Letter to the Editor] ADVANCE Blood pressure lowering in diabetes. Journal of Clinical Hypertension (Greenwich). 2009;11:108.
Webster RJ, Bayram C, Turnbull F, Patel A. Management of cardiovascular risk factors in Australian General Practice of those at highest risk. Australasian Epidemiologist. 2009;16:6-11. .
Heeley E, Peiris D, Weekes A, et al. Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (August 2009). 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. 2009;18(Suppl 3):S280.
Heeley E, Peiris D, Weekes A, et al. Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (September 2009). 6th Asia Pacific Conference Against Stroke. 2009.
Chow CK, Celermajer DS, Joshi R, Patel A, Neal B. Re-calibration of a Framingham Risk Equation for a Rural Population in India. Journal of Epidemiology and Community Health. 2009;63:379-85 .
Patel A, Joshi R, de Galan BE. [Review] Trials of cardiovascular risk management in diabetes. Current Opinion in Cardiology. 2009;24:288-94. .
Du X, Ninomiya T, de Galan BE, et al. Risk of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and artrial fibrillation – results of the ADVANCE study. European Heart Journal. 2009;30 :1128-35.
Joshi R, de Galan BE, Chalmers J, Perkovic V, Patel A. Routine blood pressure lowering and intensive glucose control in patients with type 2 diabetes: results from the ADVANCE trial. Expert Reviews in Endocrinology & Metabolism. 2009;4:111-18. .
de Galan BE, Perkovic V, Ninomiya T, et al. Routine blood pressure lowering and kidney disease in type 2 diabetes. Journal of the American Society of Nephrology. 2009;20:883-92. .
Kengne APascal, Nakamura K, Barzi F, et al. Smoking, diabetes and cardiovascular diseases in men in the Asia-Pacific Region. Journal of Diabetes. 2009;1:173-81. .
Wan Q, Harris MF, Zwar N, et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal. 2009; 157:436-441. .
Zoungas S, Ninomiya T, Huxley RR, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Annals of Internal Medicine. 2009;151:631-8.
2008
Chalmers J, Joshi R, Patel A. ADVANCES in reducing the burden of vascular disease in type 2 diabetes. Clinical and Experimental Pharmacology and Physiology. 2008;35:434-7.
Patel A. Assessing and delivering cardiovascular health care in Asia. In: 3rd International Conference on Asian Health and Wellbeing. 3rd International Conference on Asian Health and Wellbeing. Auckland, New Zealand: Centre for Asian Health Research and Evaluation; 2008.
Ayer J, Almafragy H, Patel A, Hellyer R, Celermajer DS. Body mass index is an independent determinant of left atrial size. Heart, Lung and Circulation. 2008;17:19-24.
Peiris D, Murray J, Scully D, et al. Cardiovascular risk management at a Maori-led Primary Health Organisation - findings from a cross sectional audit. New Zealand Medical Journal. 2008;121:35-46.
Patel A. Determinants of diabetes mellitus and cardiovascular diseases in the Asia Pacific region. International Diabetes Federation – Western Pacific Forum. 2008;79(Suppl 1)S7.
Beulens JW, Vingerling JR, Cruickshank JK, et al. Effects of blood pressure lowering on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Proceedings of the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) . 2008;51(Suppl 1):S476-S476.
Chalmers J, Joshi R, Kengne APascal, et al. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of evidence available in 2007. Journal of Hypertension. 2008;26 :S21-S27. .
Woodward M, Martiniuk AL, Lee CMYing, et al. Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region. European Journal of Cardiovascular Prevention and Rehabilitation. 2008;15:397-401. .

Pages